|
Name |
9-Dodecenoic acid, methyl ester
|
Molecular Formula | C13H24O2 | |
IUPAC Name* |
methyl (E)-dodec-9-enoate
|
|
SMILES |
CC/C=C/CCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C13H24O2/c1-3-4-5-6-7-8-9-10-11-12-13(14)15-2/h4-5H,3,6-12H2,1-2H3/b5-4+
|
|
InChIKey |
DUWQEMMRMJGHSA-SNAWJCMRSA-N
|
|
Synonyms |
9-Dodecenoic acid, methyl ester; 39202-17-0; 9-dodecenoic acid methyl ester; methyl (E)-dodec-9-enoate; (E)-9-Dodecenoic acid methyl ester; 9-Dodecenoic acid, methyl ester, (E)-; methyl trans-dodec-9-enoate; METHYL DODEC-9-ENOATE; SCHEMBL815437; SCHEMBL816605; Methyl (9E)-9-dodecenoate #; METHYL-TRANS-9-DODECENOATE; 55030-26-7; EC 700-618-7; Q63392724
|
|
CAS | 39202-17-0 | |
PubChem CID | 5362755 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 212.33 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 15 | QED Weighted: | 0.319 |
Caco-2 Permeability: | -4.552 | MDCK Permeability: | 0.00002910 |
Pgp-inhibitor: | 0.254 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.662 |
30% Bioavailability (F30%): | 0.985 |
Blood-Brain-Barrier Penetration (BBB): | 0.992 | Plasma Protein Binding (PPB): | 97.11% |
Volume Distribution (VD): | 2.25 | Fu: | 2.08% |
CYP1A2-inhibitor: | 0.966 | CYP1A2-substrate: | 0.572 |
CYP2C19-inhibitor: | 0.672 | CYP2C19-substrate: | 0.322 |
CYP2C9-inhibitor: | 0.515 | CYP2C9-substrate: | 0.946 |
CYP2D6-inhibitor: | 0.157 | CYP2D6-substrate: | 0.351 |
CYP3A4-inhibitor: | 0.426 | CYP3A4-substrate: | 0.129 |
Clearance (CL): | 4.429 | Half-life (T1/2): | 0.843 |
hERG Blockers: | 0.06 | Human Hepatotoxicity (H-HT): | 0.054 |
Drug-inuced Liver Injury (DILI): | 0.043 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.02 | Maximum Recommended Daily Dose: | 0.045 |
Skin Sensitization: | 0.939 | Carcinogencity: | 0.09 |
Eye Corrosion: | 0.935 | Eye Irritation: | 0.963 |
Respiratory Toxicity: | 0.456 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001645 | 0.722 | D0Z5BC | 0.444 | ||||
ENC002254 | 0.700 | D0O1PH | 0.403 | ||||
ENC001435 | 0.684 | D0O1TC | 0.400 | ||||
ENC000249 | 0.660 | D09ANG | 0.398 | ||||
ENC000259 | 0.653 | D0UE9X | 0.375 | ||||
ENC001696 | 0.630 | D0H2YX | 0.359 | ||||
ENC001660 | 0.619 | D0G2MW | 0.354 | ||||
ENC000572 | 0.619 | D0OR6A | 0.352 | ||||
ENC001657 | 0.619 | D0E4WR | 0.351 | ||||
ENC001688 | 0.619 | D0G2KD | 0.351 |